Late Breaker: SAVR vs. TAVR in Low Risk Patients...What's the Data So Far?

Moderator(s)

• 

  Thomas MacGillivray, MD

  Physician Executive Director and Chair, Cardiac Surgery
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States
• 

  Elaine Tseng, MD (she/her/hers)

  Professor of Surgery
  University of California San Francisco and San Francisco VA Medical Centers
  University of California San Francisco
  South San Francisco, California, United States

Presentations:

• 7:15 AM – 7:25 AM CT

  Five Year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-Risk Randomized Trial
  

  Invited Speaker: Michael Mack, MD – Baylor Scott & White Health
• 7:25 AM – 7:35 AM CT

  Four Year Outcomes from the EVOLUT Low Risk Trial
  

  Invited Speaker: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
• 7:35 AM – 7:45 AM CT

  Survival after SAVR in Low-Risk Patients: A Contemporary Trial Benchmark
  

  Invited Speaker: Vinay Badhwar, MD – West Virginia University
• 7:45 AM – 7:55 AM CT

  Late Breaking: Five Year Clinical and Echocardiographic Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 Trial
  

  Presenting Author: Vinod H. Thourani, MD – Piedmont Heart Institute and Piedmont Healthcare
• 7:55 AM – 8:45 AM CT

  Panel Discussion and Audience Q&A
  

  Panelist: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center

  Panelist: Michael Mack, MD – Baylor Scott & White Health

  Panelist: Vinay Badhwar, MD – West Virginia University

  Panelist: Vinod H. Thourani, MD – Piedmont Heart Institute and Piedmont Healthcare